NCT05194046View on ClinicalTrials.gov

Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

January 16, 2021

Study Completion Date

January 19, 2021

Conditions
Helicobacter Pylori Associated Gastrointestinal Disease
Interventions
DRUG

JP-1366 20mg 1capsule

will be orally administered

DRUG

Amoxicillin 500Mg Cap

Amoxicilin 500Mg 2 capsules will be orally administered

DRUG

Clarithromycin 500Mg Tab

Amoxicilin 500Mg 1 tablet will be orally administered

Trial Locations (1)

Unknown

Cha University Bundang Medical Center, Gyeonggi-do

Sponsors
All Listed Sponsors
lead

Onconic Therapeutics Inc.

INDUSTRY

NCT05194046 - Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers | Biotech Hunter | Biotech Hunter